SCHEMBL23920867

SCHEMBL23920867

Nc1nc2c(nc(SCCCc3ccccc3)n2CCO)c(=O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 3/20 0.52
NOD2 Q9HC29 4/20 0.48
TNF P01375 3/20 0.48
ALDH1A1 P00352 9/20 0.47
NOD1 Q9Y239 4/20 0.47
LMNA P02545 3/20 0.47
HPGD P15428 3/20 0.47
TP53 P04637 2/20 0.47
CXCL8 P10145 2/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 3/20 0.46
HSD17B10 Q99714 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.43
XBP1 P17861 1/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23921225 0.95 PNP (0.55) PNPNOD2TNFALDH1A1NOD1
SCHEMBL23920795 0.84 PNP (0.52) PNPTSHRHSD17B10
SCHEMBL23920847 0.84 CYP1A2 (0.46) PNPALDH1A1TP53MAPTSMN1; SMN2
SCHEMBL23921117 0.83 PNP (0.58) PNPALDH1A1TSHRHSD17B10
SCHEMBL23921084 0.82 PNP (0.49) PNPALDH1A1HPGDSMN1; SMN2MAPK1
SCHEMBL23920942 0.82 PNP (0.50) PNPMAPTTSHRHSD17B10
SCHEMBL23921224 0.82 PNP (0.60) PNPALDH1A1TSHRHSD17B10
SCHEMBL23921226 0.82 PNP (0.48) PNPALDH1A1TSHRHSD17B10
SCHEMBL23921112 0.81 PNP (0.50) PNPALDH1A1TSHRHSD17B10
SCHEMBL23921121 0.81 PNP (0.59) PNPALDH1A1HPGDMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US disclosed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 PNP 111/4885NOD2 620/4885TNF 1261/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A PNP 106/4885NOD2 634/4885TNF 1395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.